Bethanechol Chloride Injection
» Bethanechol Chloride Injection is a sterile solution of Bethanechol Chloride in Water for Injection. It contains not less than 95.0 percent and not more than 105.0 percent of the labeled amount of C7H17ClN2O2.
Packaging and storage—
Preserve in single-dose containers, preferably of Type I glass.
') + '&img=../../images/v35300/cas-590-63-6.gif',600,500);)
Identification—
It responds to Identification tests B, C, and D under Bethanechol Chloride.
Bacterial endotoxins 
85
—
It contains not more than 25.0 USP Endotoxin Units per mg of bethanechol chloride.
85—
It contains not more than 25.0 USP Endotoxin Units per mg of bethanechol chloride.
pH 791:
between 5.5 and 7.5.
791:
between 5.5 and 7.5.
Limit of 2-hydroxypropyltrimethyl ammonium chloride—
Diluent, Mobile phase, System suitability solution, and Chromatographic system—
Prepare as directed in the Assay.
2-Hydroxypropyltrimethyl ammonium chloride solution—
Transfer 50.0 mg of bethanechol chloride into a 50-mL volumetric flask. Add about 40 mL of 0.1 N sodium hydroxide, and sonicate until fully dissolved. Dilute with 0.1 N sodium hydroxide to volume, and allow to stand for five days to allow adequate time for conversion from bethanechol to 2-hydroxypropyltrimethyl ammonium chloride. Chromatograph as directed for Procedure to verify the presence and location of the peak for 2-hydroxypropyltrimethyl ammonium chloride.
Standard solution—
Use the Standard preparation, prepared as directed in the Assay.
Test solution—
Use the Assay preparation.
Procedure—
Separately inject equal volumes (about 50 µL) of the 2-Hydroxypropyltrimethyl ammonium chloride solution, the Standard solution, and the Test solution into the chromatograph, record the chromatograms, and measure the responses for the bethanechol and 2-hydroxypropyltrimethyl ammonium chloride peaks. Calculate the percentage of 2-hydroxypropyltrimethyl ammonium chloride in each mL of the Injection taken by the formula:
100(CS / Ci)(ri / rS)
in which CS is the concentration, in mg per mL, of USP Bethanechol Chloride RS in the Standard solution; Ci is the concentration, in mg per mL, of bethanechol chloride in the Test solution; ri is the peak response for 2-hydroxypropyltrimethyl ammonium chloride obtained from the Test solution; and rS is the peak response for bethanechol obtained from the Standard solution. Not more than 4.0% is found.
Other requirements—
It meets the requirements under Injections 1.
1.
Assay—
Diluent—
Transfer 10 mg of calcium chloride and 10 mg of magnesium chloride to a 100-mL volumetric flask, dissolve in and dilute with water to volume, and mix.
Mobile phase—
Prepare a filtered and degassed solution of 20 mM methanesulfonic acid. Make adjustments if necessary (see System Suitability under Chromatography 621).
621).
System suitability solution—
Transfer 25 mg of USP Bethanechol Chloride RS, accurately weighed, to a 25-mL volumetric flask, and add 15 mL of water, 2.0 mL of the Diluent, and 0.5 mL of 0.1 N sodium hydroxide. Dilute with water to volume, and mix.
Standard preparation—
Dissolve an accurately weighed quantity of USP Bethanechol Chloride RS in water, and dilute quantitatively, and stepwise if necessary, with water to obtain a solution having a known concentration of about 1.0 mg per mL.
Assay preparation—
Dilute an accurately measured volume of Injection, if necessary, with water to obtain a solution having a concentration of about 1.0 mg per mL.
Chromatographic system (see Chromatography 621)—
The liquid chromatograph is equipped with a conductivity detector and a 4-mm × 25-cm column that contains packing L53. The flow rate is about 1 mL per minute. Chromatograph the System suitability solution, and record the peak responses as directed for Procedure: the relative retention times are 1.0 for sodium, 1.4 for magnesium, 1.6 for calcium, 2.0 for 2-hydroxypropyltrimethyl ammonium chloride, and 2.8 for bethanechol; the resolution, R, between the calcium ion and 2-hydroxypropyltrimethyl ammonium chloride is not less than 2.0; the column efficiency determined from the bethanechol peak is not less than 350 theoretical plates; the tailing factor is not more than 4.5; and the relative standard deviation for replicate injections is not more than 2.0%.
621)—
The liquid chromatograph is equipped with a conductivity detector and a 4-mm × 25-cm column that contains packing L53. The flow rate is about 1 mL per minute. Chromatograph the System suitability solution, and record the peak responses as directed for Procedure: the relative retention times are 1.0 for sodium, 1.4 for magnesium, 1.6 for calcium, 2.0 for 2-hydroxypropyltrimethyl ammonium chloride, and 2.8 for bethanechol; the resolution, R, between the calcium ion and 2-hydroxypropyltrimethyl ammonium chloride is not less than 2.0; the column efficiency determined from the bethanechol peak is not less than 350 theoretical plates; the tailing factor is not more than 4.5; and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure—
Separately inject equal volumes (about 50 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in mg, of bethanechol chloride (C7H17ClN2O2) in each mL of the Injection taken by the formula:
C(rU / rS)
in which C is the concentration, in mg per mL, of USP Bethanechol Chloride RS in the Standard preparation; and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information—
Please check for your question in the FAQs before contacting USP.
| Topic/Question | Contact | Expert Committee |
|---|---|---|
| Monograph | Ravi Ravichandran, Ph.D.
Principal Scientific Liaison 1-301-816-8330 |
(SM42010) Monographs - Small Molecules 4 |
| Reference Standards | RS Technical Services 1-301-816-8129 rstech@usp.org |
|
| 85 |
Radhakrishna S Tirumalai, Ph.D.
Principal Scientific Liaison 1-301-816-8339 |
(GCM2010) General Chapters - Microbiology |
USP35–NF30 Page 2351
Pharmacopeial Forum: Volume No. 28(4) Page 1072